Indole-based small molecules exert a notable anti-NSCLC action through multiple mechanisms such as the induction of apoptosis and the inhibition of crucial biological targets including protein kinases (e.g., Akt) [58,59,60,61,62]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.